Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions. The Advanced Therapies segment offers advanced therapy products, services, and solutions to the therapy departments of healthcare providers. The Diagnostics segment provides diagnostic products and services, including a range of testing applications, in the areas of laboratory, point of care, and molecular diagnostics. Siemens Healthineers AG is based in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
Industry, Sector and Symbol
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone49 69 6682 6602
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Siemens Healthineers (ETR:SHL) Frequently Asked Questions
What is Siemens Healthineers' stock symbol?
Siemens Healthineers trades on the ETR under the ticker symbol "SHL."
What price target have analysts set for SHL?
19 brokerages have issued 12 month price targets for Siemens Healthineers' stock. Their forecasts range from €33.50 to €43.00. On average, they expect Siemens Healthineers' share price to reach €37.84 in the next year. This suggests a possible upside of 4.5% from the stock's current price. View Analyst Price Targets for Siemens Healthineers.
What is the consensus analysts' recommendation for Siemens Healthineers?
19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Siemens Healthineers in the last year. There are currently 13 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Siemens Healthineers.
Has Siemens Healthineers been receiving favorable news coverage?
News stories about SHL stock have trended somewhat positive on Friday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Siemens Healthineers earned a news impact score of 1.7 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next several days.
Who are some of Siemens Healthineers' key competitors?
Some companies that are related to Siemens Healthineers include BioMark Diagnostics (BUX), BioNano Genomics (BNGOU), Breathtec Biomedical (BTH), Cambridge Cognition (COG), Carl Data Solutions (CRL), Carl Zeiss Meditec (AFX), Co-Diagnostics (CODX), Deepmatter Group (DMTR), EPIGENOMICS AG/S (EPGNY), Eternity Healthcare (ETAH), Genedrive (GDR), Integral Diagnostics (IDX), MaxCyte (MXCT), Medical Imaging (MEDD) and Oncimmune (ONC).
What other stocks do shareholders of Siemens Healthineers own?
Who are Siemens Healthineers' key executives?
Siemens Healthineers' management team includes the folowing people:
- Dr. Jochen Schmitz, CFO & Member of Management Board (Age 53)
- Mr. Michael Reitermann, Chief Markets & Diagnostics Officer and Member of Management Board (Age 57)
- Mr. Florian Flossmann, Head of Investor Relations
What is Siemens Healthineers' stock price today?
One share of SHL stock can currently be purchased for approximately €36.20.
What is Siemens Healthineers' official website?
How can I contact Siemens Healthineers?
The company can be reached via phone at 49 69 6682 6602.
MarketBeat Community Rating for Siemens Healthineers (ETR SHL)
MarketBeat's community ratings are surveys of what our community members think about Siemens Healthineers and other stocks. Vote "Outperform" if you believe SHL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SHL will underperform the S&P 500 over the long term. You may vote once every thirty days.
